Reuters logo
BRIEF-Biotech Capital says FY operating revenue $28,496, down 60 percent
August 29, 2017 / 9:39 AM / a month ago

BRIEF-Biotech Capital says FY operating revenue $28,496, down 60 percent

Aug 29 (Reuters) - Biotech Capital Ltd

* FY operating revenue $28,496, down 60 percent

* FY loss after tax attributable to equity holders $516,527 versus loss of $870,780 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below